Publikationen in Zusammenarbeit mit Forschern von Hospital Universitario Puerta de Hierro (7)

2018

  1. Phase II trial of ifosfamide in combination with the VEGFR inhibitor sorafenib in advanced soft tissue sarcoma: a Spanish group for research on sarcomas (GEIS) study

    Investigational New Drugs, Vol. 36, Núm. 3, pp. 468-475

2012

  1. Trabectedin in pre-treated patients with advanced or metastatic soft tissue sarcoma: A phase II study evaluating co-treatment with dexamethasone

    Investigational New Drugs, Vol. 30, Núm. 2, pp. 729-740

2011

  1. Randomized phase II study comparing gemcitabine plus dacarbazine versus dacarbazine alone in patients with previously treated soft tissue sarcoma: A Spanish group for research on sarcomas study

    Journal of Clinical Oncology, Vol. 29, Núm. 18, pp. 2528-2533

  2. Value of FDG-PET for monitoring treatment response in patients with advanced GIST refractory to high-dose imatinib. A multicenter GEIS study

    Quarterly Journal of Nuclear Medicine and Molecular Imaging, Vol. 55, Núm. 6, pp. 680-687

2010

  1. Imatinib plus low-dose doxorubicin in patients with advanced gastrointestinal stromal tumors refractory to high-dose imatinib: A phase I-II study by the Spanish group for research on sarcomas

    Cancer, Vol. 116, Núm. 15, pp. 3692-3701

  2. Phase I study of oral vinorelbine and capecitabine in patients with metastatic breast cancer

    Anticancer Research, Vol. 30, Núm. 6, pp. 2255-2261

1998

  1. Detection of BRCA1 gene mutations in families with breast cancer patients and their healthy relatives

    International Journal of Oncology, Vol. 13, Núm. 2, pp. 275-279